About Samantha Haeberlein
Samantha Haeberlein is a director at ALZpath.
Experience
This experience comes from SEC filings. The years are when the filings name Samantha Haeberlein in the role, so the role may have started earlier or lasted longer.
ALZpath, Inc.
Director
2026 · Carlsbad, CA
Licenses an antibody to diagnostic companies for use in Alzheimer's blood tests.
Key Colleagues at Startups
The people Samantha Haeberlein works with at each company, as listed on that company's latest Form D.
ALZpath, Inc. · Form D, Jul 21, 2026
Michael Banville
CEO and President
Harry Johns
Director
John Courtney
Director
John Hensing
Director
Irit Rappley
Director
Jerre Stead
Co-Founder, Chair